Frontlight ResearchEarly access
Trial site
Sichuan Cancer Hospital and Institute
- 3running trials
- 7closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer5 trials
- Lung cancer4 trials
- Cervical cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Completed6 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- BeiGene6 trials
- Yongtao Han2 trials
- BeOne Medicines1 trial
- Peking Union Medical College Hospital1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cervical cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCC
Site data: ClinicalTrials.govUpdated 12 Nov 2026